This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Hantavirus pulmonary syndrome | |
|---|---|
| Name | Hantavirus pulmonary syndrome |
| Field | Infectious disease |
| Symptoms | Fever, myalgia, cough, shortness of breath |
| Complications | Respiratory failure, shock |
| Onset | Days to weeks after exposure |
| Causes | Hantaviruses |
| Risks | Rodent exposure, rural and occupational settings |
| Diagnosis | Serology, PCR, clinical criteria |
| Prevention | Rodent control, personal protective equipment, public health measures |
| Treatment | Supportive care, intensive care, ECMO in severe cases |
| Prognosis | Variable; case fatality historically high |
Hantavirus pulmonary syndrome is an acute zoonotic respiratory illness caused by several New World hantaviruses, first recognized in the Americas in the 1990s. It presents with a febrile prodrome followed by rapid development of noncardiogenic pulmonary edema and cardiopulmonary shock; outbreaks have prompted coordinated responses from public health agencies and international organizations. Surveillance, rodent ecology studies, occupational health guidance, and critical care advances have shaped clinical and prevention approaches worldwide.
Hantavirus pulmonary syndrome emerged as a public health concern after a 1993 cluster in Four Corners, prompting investigations by the Centers for Disease Control and Prevention, collaborations with the World Health Organization, and research by virologists at institutions such as the National Institutes of Health and university laboratories. The syndrome is associated with New World hantaviruses including the Sin Nombre virus, and has been reported across North and South America, involving interactions among researchers from universities like University of New Mexico, public health departments such as the New Mexico Department of Health, and federal agencies including the Pan American Health Organization.
Initial manifestations include acute fever, severe myalgia, headache, and gastrointestinal symptoms; clinicians at hospitals such as Presbyterian Hospital (Albuquerque) and intensive care units in major centers like Mayo Clinic have reported rapid progression to cough and dyspnea. The cardiopulmonary phase can involve hypoxemia, noncardiogenic pulmonary edema, and hypotension requiring vasopressors and ventilatory support; case series published by teams at the Harvard Medical School and Johns Hopkins Hospital document rapid deterioration. Laboratory abnormalities noted by investigators at institutions including University of California, San Francisco and Stanford University encompass thrombocytopenia and hemoconcentration; historical case reports from regions like Chilean Patagonia and Buenos Aires illustrate variable presentations.
HPS results from infection by hantaviruses of the family Hantaviridae, notably the Sin Nombre virus, with mammalian reservoir hosts such as the deer mouse implicated through field studies by ecologists at organizations like the United States Geological Survey and universities including University of New Mexico. Pathogenesis involves endothelial dysfunction, immune-mediated capillary leak, and pulmonary edema; immunopathology described in research from laboratories at the Rocky Mountain Laboratories and Centers for Disease Control and Prevention implicates dysregulated cytokine responses studied by investigators from institutions such as Columbia University and University of California, Berkeley. Viral genomics and phylogenetic analyses by groups at the Sanger Institute and Los Alamos National Laboratory have elucidated relationships among New World hantaviruses and their rodent hosts.
Transmission to humans typically follows inhalation of aerosolized excreta from infected rodents, documented in field investigations in rural settings across regions such as New Mexico, Colorado, Argentina, and Brazil. Reservoir species include the Peromyscus maniculatus (deer mouse), identified in ecological studies by researchers from University of California, Santa Cruz and the Smithsonian Institution, and other sigmodontine rodents characterized by mammalogists at institutions such as University of Texas at Austin and Museo Argentino de Ciencias Naturales. Occupational and recreational exposures linked to outbreaks have involved workers and campers associated with sites overseen by agencies like the National Park Service and universities such as University of Washington. Human-to-human transmission is rare but documented for certain hantaviruses in parts of Argentina and Chile, prompting epidemiological investigations by public health teams from Instituto Nacional de Enfermedades Infecciosas and collaborations with the World Health Organization.
Diagnosis integrates clinical criteria with laboratory confirmation via serology (IgM, rising IgG) and molecular detection (RT-PCR), tests developed and validated at reference laboratories including the Centers for Disease Control and Prevention, Public Health England, and the Instituto Nacional de Salud Pública (Mexico). Imaging shows bilateral interstitial and alveolar infiltrates on chest radiography or CT, findings described in case series from tertiary centers such as Massachusetts General Hospital and Brigham and Women's Hospital. Differential diagnosis considered by clinicians at facilities like King's College Hospital includes other causes of acute respiratory distress such as severe influenza and atypical pneumonias; laboratory support from institutions such as Mayo Clinic Laboratories aids definitive identification.
Prevention emphasizes rodent control, environmental sanitation, and education coordinated by agencies including the Centers for Disease Control and Prevention, Pan American Health Organization, and local health departments like the New Mexico Department of Health. Personal protective measures for at-risk workers are guided by occupational health programs at institutions such as Occupational Safety and Health Administration and National Institute for Occupational Safety and Health, which recommend gloves, respirators, and ventilation for cleaning rodent-infested buildings. Public health interventions documented after outbreaks have involved wildlife management by the United States Fish and Wildlife Service, community outreach through organizations like the American Red Cross, and research on vaccines and antivirals at pharmaceutical companies and research centers such as GlaxoSmithKline, Moderna, and National Institutes of Health collaborative programs.
Treatment is primarily supportive with aggressive cardiopulmonary intensive care, use of vasopressors, mechanical ventilation, and extracorporeal membrane oxygenation (ECMO) in severe cases, practices refined at centers of excellence including Cleveland Clinic, University of Pittsburgh Medical Center, and Children's Hospital of Philadelphia. Antiviral therapies such as ribavirin have shown variable results in trials conducted at institutions like Osaka University and Charité – Universitätsmedizin Berlin; clinical management protocols have been developed by panels including experts from Infectious Diseases Society of America and the European Centre for Disease Prevention and Control. Overall prognosis varies with rapid recognition and critical care availability; historical case-fatality rates reported by the Centers for Disease Control and Prevention and studied in cohort analyses from universities such as University of California, San Diego indicate substantial mortality without prompt intervention.
Category:Zoonoses